Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

10293	Companies
213141	Keywords
142919	Articles
112860	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 04/22/2026 at 06:35, 5 days 12 hours ago

Formycon's 2025 Financial Results and Strategic Outlook for 2026

Strategic Partnerships 2026 Financial Forecast Formycon 2025 Results Biosimilar Pipeline Progress FYB4Growth Strategy
PRESS RELEASE

published on 04/22/2026 at 06:30, 5 days 12 hours ago

Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships
Formycon AG reports successful financial year 2025 with operational progress, market growth, and strategic partnerships. Forecast for 2026 includes revenue growth and positive EBITDA

Strategic Partnerships Formycon AG Operational Progress Market Presence Financial Year 2025
BRIEF

published on 04/20/2026 at 06:35, 7 days 12 hours ago

Formycon Announces 2025 Financial Results Conference Call and 2026 Investor Conferences

Conference Call Formycon AG Management Board Financial Results 2025 Investor Conferences 2026
PRESS RELEASE

published on 04/20/2026 at 06:30, 7 days 12 hours ago

Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026
Formycon AG to hold Conference Call on Results of FY 2025 and participate in international Investor Conferences in Q2 2026. Details and registration at provided links

Conference Call Investor Conferences Formycon AG Biosimilars Financial Year 2025
BRIEF

published on 04/15/2026 at 19:57, 11 days 23 hours ago

Formycon AG Reports Improved Preliminary Figures for 2025 Fiscal Year

Working Capital Annual Financial Statements Formycon AG 2025 Fiscal Year Group EBITDA
PRESS RELEASE

published on 04/15/2026 at 19:52, 11 days 23 hours ago

EQS-Adhoc: Formycon AG:
Formycon AG announces improved preliminary figures for the 2025 fiscal year, including adjusted EBITDA and working capital, with annual financial statements publication set for April 22, 2026

Financial Statements EBITDA Formycon AG Preliminary Figures 2025 Fiscal Year
BRIEF

published on 03/19/2026 at 06:35, 1 month 8 days ago

Formycon Secures Licensing for Biosimilar in Europe and Beyond

Market Expansion Formycon Retinal Diseases Biosimilar Licensing Patent Settlement
PRESS RELEASE

published on 03/19/2026 at 06:30, 1 month 8 days ago

Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer

Bayer Biosimilar Formycon Regeneron Aflibercept
BRIEF

published on 03/18/2026 at 18:58, 1 month 9 days ago

Formycon AG Delays 2025 Financial Statement Publication

Regulatory Compliance Financial Statement Formycon AG Postponement 2025 Results
PRESS RELEASE

published on 03/18/2026 at 18:53, 1 month 9 days ago

EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025 due to internal system changes, extended reconciliation work, and audit delays

Formycon AG Postponement 2025 Audited Financial Statements Internal System Changes

Accesswire

Published on 04/27/2026 at 17:15, 2 hours 13 minutes ago

SouthGobi Announces Discloseable Transaction Entering Into a Build-Transfer Agreement in Relation to the Dry Coal Separation System
Published on 04/27/2026 at 15:00, 4 hours 28 minutes ago

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Published on 04/27/2026 at 14:25, 5 hours 3 minutes ago

Guanajuato Silver Files Technical Report for Bolanitos Mine
Published on 04/27/2026 at 14:00, 5 hours 28 minutes ago

GameSquare Announces Record Q1 2026 Bookings of Over $10 Million for its GameSquare Experiences Division
Published on 04/27/2026 at 13:00, 6 hours 28 minutes ago

Core Silver and Arcus Development Group Enter into a Binding Letter of Intent for a Business Combination Transaction and Sign a Definitive Option Agreement for the Touleary Project

View all ACCESSWIRE

EQS Group

Published on 04/27/2026 at 19:07, 20 minutes ago

Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
Published on 04/27/2026 at 18:50, 37 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/27/2026 at 18:20, 1 hour 7 minutes ago

Convening Notice of the Company’s Extraordinary General Meeting to be held on 28 May 2026
Published on 04/27/2026 at 18:03, 1 hour 25 minutes ago

Linde Declares Dividend in Second Quarter 2026
Published on 04/27/2026 at 17:45, 1 hour 43 minutes ago

Hikvision releases 2025 full-year and 2026 first-quarter financial results

Les Echos

Published on 04/27/2026 at 17:45, 1 hour 43 minutes ago

Convocation annual general meeting of May 27, 2026
Published on 04/27/2026 at 17:45, 1 hour 43 minutes ago

Weekly share buyback
Published on 04/27/2026 at 17:35, 1 hour 53 minutes ago

Disclosure of transactions in own shares from April 20 to April 24, 2026
Published on 04/27/2026 at 11:42, 7 hours 45 minutes ago

Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 24, 2026
Published on 04/24/2026 at 17:45, 3 days 1 hour ago

Share buyback for cancellation

View all LES ECHOS COMFI WIRE